KEGG   GLYCAN: G00090
Entry
G00090                      Glycan                                 
Name
V3Fuc,III3Fuc-nLc6Cer
Composition
(Gal)3 (Glc)1 (GlcNAc)2 (LFuc)2 (Cer)1
Mass
1347.2 (Cer)
Structure
Reaction
R06221
Pathway
map00601  Glycosphingolipid biosynthesis - lacto and neolacto series
Enzyme
2.4.1.65        2.4.1.152       2.4.1.-
Brite
Lipids [BR:br08002]
 SP  Sphingolipids
  SP05 Neutral glycosphingolipids
   SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)
    G00090  Gal-beta1->4(Fuc-alpha1->3)GlcNAc-beta1->3Gal-beta1->4(Fuc-alpha1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer
Cancer-associated carbohydrates [br08441.html]
 Glycosphingolipid
  G00090
Reference
1  [PMID:2960671]
  Authors
Holmes EH, Hakomori S, Ostrander GK.
  Title
Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed beta 1----3N-acetylglucosaminyltransferase.
  Journal
J Biol Chem 262:15649-58 (1987)
Other DBs
LinkDB
KCF data

NODE        9
            1   Cer        31     0
            2   Glc        23     0
            3   Gal        15     0
            4   GlcNAc      6     0
            5   Gal        -3     4
            6   LFuc       -3    -4
            7   GlcNAc    -12     4
            8   Gal       -21     8
            9   LFuc      -21     0
EDGE        8
            1     2:b1    1:1  
            2     3:b1    2:4  
            3     4:b1    3:3  
            4     5:b1    4:4  
            5     6:a1    4:3  
            6     7:b1    5:3  
            7     8:b1    7:4  
            8     9:a1    7:3

DBGET integrated database retrieval system